These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
155 related items for PubMed ID: 4259330
1. [A new pharmacological association in therapy of dyslipidemic and arteriosclerotic syndromes]. Cucinotta D. Minerva Med; 1972 Feb 28; 63(15):870-85. PubMed ID: 4259330 [No Abstract] [Full Text] [Related]
2. [Hypolipemic effects of a new tetralin derivative: compound 13473-Su (Ciba)]. Ciobanu V, Zălaru MC, Ciocan A, Mihăilescu S. Stud Cercet Med Interna; 1971 Feb 28; 12(1):67-80. PubMed ID: 5565781 [No Abstract] [Full Text] [Related]
3. [Orthopedic and traumatologic clinical experimentation with a heparin preparation]. Sabetta F, Lanfranchi R. Minerva Ortop; 1969 Apr 28; 20(4):149-52. PubMed ID: 4247658 [No Abstract] [Full Text] [Related]
4. [On the comparative results of the use of Clarisco in peripheral vascular diseases]. Vittori C, Borri P, Bianchi V. Minerva Med; 1970 Dec 05; (97 Suppl):5585-640. PubMed ID: 4250224 [No Abstract] [Full Text] [Related]
8. [Polyunsaturated phosphatidyl choline (EPL) in the treatment of cerebral arteriosclerosis and arteriosclerosis of the lower extremities]. Ciammaichella A, Solitro A, Arcuri P. Clin Ter; 1975 Jul 15; 74(1):55-62. PubMed ID: 1222517 [No Abstract] [Full Text] [Related]
10. [Clinical experiences on the normolipemizing effects of a new pharmaceutical preparation]. Legnani F. Policlinico Med; 1966 Feb 15; 73(1):60-4. PubMed ID: 4223196 [No Abstract] [Full Text] [Related]
11. [Clinical evaluation of a new preparation with liver-protective and anti-anemic action]. Cairella M. Clin Ter; 1966 Dec 15; 39(6):567-76. PubMed ID: 4232883 [No Abstract] [Full Text] [Related]
12. Studies on arteriosclerotic diathesis. II. Rate of cholesterol esterification and fatty acid pattern in the serum. Ishigami K. Kumamoto Med J; 1968 Sep 30; 21(3):114-21. PubMed ID: 5708371 [No Abstract] [Full Text] [Related]
13. [Studies on the effect of d-thyroxine in patients with increased serum lipid level]. Steger H. Wien Klin Wochenschr; 1968 Nov 22; 80(47):887-98. PubMed ID: 5717659 [No Abstract] [Full Text] [Related]
15. [The treatment of essential hyperlipidemia with clofibrate]. Reuter W, Seifert A. Z Gesamte Inn Med; 1969 Jan 01; 24(1):Suppl:184-7. PubMed ID: 4918619 [No Abstract] [Full Text] [Related]
16. [Current trends in the therapy of arteriosclerotic disease]. Toscano S. G Clin Med; 1974 Jan 01; 55(1):27-39. PubMed ID: 4369524 [No Abstract] [Full Text] [Related]
17. [Treatment of hyperdyslipidemia in chronic atherosclerotic peripheral obliterating arteriopathies of the lower limbs]. Bagliani A, Argenteri A, La Rosa A. Clin Ter; 1982 Dec 31; 103(6):647-61. PubMed ID: 7160147 [No Abstract] [Full Text] [Related]
18. [Improvement of speech discrimination with cytoflavin in patients with chronic sensorineural deafness]. Zhuravskiĭ SG. Vestn Otorinolaringol; 2010 Dec 31; (4):82-6. PubMed ID: 21105353 [No Abstract] [Full Text] [Related]
19. [The use of cytoflavin for the treatment of chronic brucellosis]. Shul'diakov AA, Liapina EP, Soboleva LA, Reshetnikov AA, Zubareva EV, Trubetskov AD, Anashchenko AV, Evdokimov AV. Klin Med (Mosk); 2011 Dec 31; 89(2):56-8. PubMed ID: 21574446 [Abstract] [Full Text] [Related]
20. [Clinico-experimental studies on decreasing blood lipids in geriatrics]. Bracharz H, Laas H. Med Monatsschr; 1966 Oct 31; 20(10):471-6. PubMed ID: 5978465 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]